| Breakdown | Mar 2026 | Mar 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 359.95B | 359.81B | 124.09B | 129.91B | 112.10B |
| Gross Profit | 37.60B | 34.94B | 13.05B | 13.58B | 10.73B |
| EBITDA | 12.16B | 16.76B | 8.84B | 4.80B | 2.86B |
| Net Income | 7.44B | 9.39B | 7.02B | 3.06B | 1.87B |
Balance Sheet | |||||
| Total Assets | 250.81B | 230.50B | 96.51B | 88.41B | 72.65B |
| Cash, Cash Equivalents and Short-Term Investments | 35.97B | 206.54M | 10.25B | 19.03B | 9.70B |
| Total Debt | 46.92B | 38.40B | 27.70B | 25.82B | 11.76B |
| Total Liabilities | 113.91B | 662.02M | 45.22B | 43.69B | 30.34B |
| Stockholders Equity | 136.89B | 131.45B | 51.29B | 44.72B | 42.31B |
Cash Flow | |||||
| Free Cash Flow | -1.99B | 11.68B | 8.61B | -2.81B | -8.24B |
| Operating Cash Flow | -1.49B | 13.18B | 9.07B | -2.55B | -8.09B |
| Investing Cash Flow | 3.79B | -101.98M | -17.37B | 150.00M | 2.55B |
| Financing Cash Flow | 1.61B | -117.73M | -1.24B | 11.55B | 6.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥73.49B | 12.98 | ― | 2.87% | 50.78% | 26.58% | |
74 Outperform | ¥223.86B | 6.85 | 17.09% | 2.94% | 20.29% | 94.13% | |
73 Outperform | ¥80.76B | 16.05 | 5.37% | 3.41% | -1.40% | 13.91% | |
67 Neutral | ¥65.03B | 22.64 | ― | 3.56% | -3.47% | -38.19% | |
62 Neutral | ¥98.55B | 9.84 | ― | 2.41% | 50.28% | 79.25% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | ¥99.40B | 0.35 | ― | ― | 0.04% | -20.82% |